Clinical Trial Details
Trial ID: | L0279 |
Source ID: | NCT00452478 |
Associated Drug: | Lanthanum Carbonate |
Title: | Conversion From Standard Phosphate Binder Therapy to FosrenolĀ® (Lanthanum Carbonate) in Chronic Kidney Disease Stage 5 |
Acronym: | |
Status: | TERMINATED |
Study Results: | NO |
Results: | |
Conditions: | Kidney Diseases |
Interventions: | DRUG: Lanthanum carbonate |
Outcome Measures: | Primary: Percentage of subjects achieving serum phosphorus levels of less than or equal to 1.78 mmol/L (5.5 mg/dL) following treatment with Fosrenol at Week 12 compared to treatment with their previous phosphate binder therapy, 12 weeks | Secondary: The maintenance of mean serum phosphorus levels following treatment with 2250 mg/day of Fosrenol, at Week 2 compared to baseline|Biochemical and haematological parameters, measured throughout the study|Assess safety & tolerability, Throughout the study |
Sponsor/Collaborators: | Sponsor: Shire |
Gender: | ALL |
Age: | ADULT, OLDER_ADULT |
Phases: | PHASE4 |
Enrollment: | 68 |
Study Type: | INTERVENTIONAL |
Study Designs: | Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT |
Start Date: | 2007-05-22 |
Completion Date: | 2007-12-10 |
Results First Posted: | |
Last Update Posted: | 2021-05-25 |
Locations: | Landeskrankenhaus Feldkirch, Abteilung fur Nephrologie und dialyse, Feldkirch Tisis, A-6807, Austria|Krankenhaus Elisabethinen/Dialysestation, Linz, A-4010, Austria|Ziekenhuis Zuid Oost Limburg, Genk, 3600, Belgium|Frederica Sygehus, Fredericia, 7000, Denmark|Holbaek Sykehus, Holbaek, DK-4300, Denmark|Sygehus Viborg, Viborg, 88 00, Denmark|Dialysezentrum Barmbek, Hamburg, 22297, Germany|Dialysezentrum Heilbronn, Heilbronn, 74076, Germany|Dialyse Leipzig, Leipzig, 04178, Germany|Nephrologisches Zentrum Emsland, Lingen, 49808, Germany|nephrologische Schwerpunktpraxis, Oldenburg, 26127, Germany|diabetologische Schwerpunktpraxis, Villingen-Schwenningen, 78054, Germany|University of Milan, San Paolo Hospital, Renal Division, Milan, Italy|Gelre Ziekenhuizen, Apeldoorn, 7334 DZ, Netherlands |
URL: | https://clinicaltrials.gov/show/NCT00452478 |

Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
---|